ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
아스퍼거 증후군 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.5%로 성장할 전망이며, 21억 2,000만 달러로 성장이 예측됩니다. 이 미래 성장의 주요 촉진 요인으로는 자폐 스펙트럼 장애에 대한 인식 제고, 조기 진단 기술의 광범위한 도입, 행동 및 발달 치료 옵션에 대한 접근 확대, 유리한 헬스케어 시책 및 정부 프로그램, 원격의료 및 정신건강 플랫폼 확대, 심리상태 발생률 증가 등을 들 수 있습니다. 예측 기간 중 예상되는 새로운 동향으로는 조기진단 인공지능(AI) 이용, 원격치료 서비스 대두, 개별화 행동요법 혁신, 웨어러블 모니터링 툴 도입 등을 들 수 있습니다.
신경질환의 이환율 상승은 향후 수년간 아스퍼거 증후군 시장의 성장을 가속할 것으로 예측됩니다. 뇌, 척수, 신경에 영향을 미치는 신경장애는 인지장애, 운동장애, 감각장애를 통해 나타납니다. 노화는 신경세포 기능에 영향을 주어 뇌의 가소성을 저하시키고 산화 스트레스를 높여주며, 이 모든 것이 이러한 질환의 개발 및 진행에 기여하기 때문입니다. 이러한 장애는 뇌의 발달과 기능, 특히 사회적 상호작용과 의사소통과 관련된 영역에 영향을 미쳐 아스퍼거 증후군 발병의 한 원인이 됩니다. 이러한 장애는 사회적 신호에 어려움을 일으키거나 반복적인 행동을 조장하거나 특정 흥미에 강하게 집중함으로써 행동에 영향을 미칩니다. 예를 들어 2024년 7월 영국 정부기관인 국민보건서비스(NHS)는 2024년 6월 30일까지 48만 7,432명의 환자가 치매 진단을 받았다고 보고했습니다. 그 결과 신경질환 유병률 증가가 아스퍼거 증후군 시장을 추진하는 중요한 요인이 되고 있습니다.
아스퍼거 증후군 시장의 주요 기업은 근본적인 유전적 원인을 다루고, 인지 기능 및 사회 기능을 개선하며, 맞춤 치료 전략을 지원하기 위해 유전자 치료 등의 선진적 치료법의 개발에 점점 투자하고 있습니다. 유전자 치료란 질병을 예방 또는 치료하기 위해 사람의 유전자를 수정하는 치료법입니다. 예를 들어 2024년 1월 미국의 생명공학 기업인 재규어진테라피는 JAG201의 시험신약(IND) 신청에 대해 미국 식품의약국(FDA)으로부터 인가를 받았습니다. 이 유전자 치료는 자폐 스펙트럼 장애(ASD)와 페란-맥더미드 증후군(PMS)의 유전적 형태를 치료하는 것을 목적으로 하고 있습니다. FDA 승인으로 이들 질환의 주요 유전적 요인인 SHANK3 결손을 수정하는 JAG201의 가능성을 평가하는 임상검사가 가능해지면서 현재 치료 선택지가 한정된 위중한 신경발달 질환에 대한 혁신적인 치료법 창출을 위한 재규어의 헌신적인 노력이 부각되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 아스퍼거 증후군 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 아스퍼거 증후군 시장 : 성장률 분석
세계의 아스퍼거 증후군 시장 실적 : 규모 및 성장(2019-2024년)
세계의 아스퍼거 증후군 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 아스퍼거 증후군 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 아스퍼거 증후군 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
아스퍼거 증후군
광범위 발달장애
자폐증
붕괴성 장애
세계의 아스퍼거 증후군 시장 : 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
약 요법
항정신병제
선택적 세로토닌 재흡수 억제제(SSRI)
각성제
수면제
세계의 아스퍼거 증후군 시장 : 진단별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
정신장애 진단 및 통계 수동(DSM)-IV
감별 진단
어린 시절 아스퍼거 증후군 테스트
길리엄 아스퍼거 장애 척도(Gads)
크루그 아스퍼거 장애 지수(Kadi)
기타
세계의 아스퍼거 증후군 시장 : 연령층별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
유아
청소년
성인
세계의 아스퍼거 증후군 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
진단센터
약국
약국
기타
세계의 아스퍼거 증후군 시장 : 아스퍼거 증후군별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경미한 아스퍼거 증후군
중도 아스퍼거 증후군
심한 아스퍼거 증후군
세계의 아스퍼거 증후군 시장 : 광범성 발달 장애별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
광범위 발달장애(PDD-NOS)
렛 증후군
소아 붕괴성 장애
세계의 아스퍼거 증후군 시장 : 자폐증별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
고기능 자폐증
저기능 자폐증
전형적인 자폐증
세계의 아스퍼거 증후군 시장 : 붕괴성 장애별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
지발성 자폐증
퇴행성 자폐증
행동 붕괴의 서브 유형
제7장 지역별 및 국가별 분석
세계의 아스퍼거 증후군 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 아스퍼거 증후군 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
아스퍼거 증후군 시장 : 경쟁 구도
아스퍼거 증후군 시장 : 기업 프로파일
Pfizer Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AbbVie Inc.
Bristol-Myers Squibb Company
제31장 기타 주요 기업 및 혁신 기업
Novartis AG
GSK plc
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
Boehringer Ingelheim
Otsuka Pharmaceutical Co. Ltd.
Sun Pharmaceutical Industries Ltd.
Neurocrine Biosciences Inc.
Acadia Pharmaceuticals Inc.
PsychoGenics Inc.
AdvaCare Pharma
Sage Therapeutics Inc.
Curemark LLC
PaxMedica Inc.
Yamo Pharmaceuticals
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
아스퍼거 증후군 시장(2029년) : 새로운 기회를 제공하는 국가
아스퍼거 증후군 시장(2029년) : 새로운 기회를 제공하는 부문
아스퍼거 증후군 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Asperger syndrome is a neurodevelopmental condition that falls within the autism spectrum. It is marked by challenges in social interactions, narrowly focused interests, and repetitive behaviors, all occurring without significant delays in language skills or intellectual development. Individuals with Asperger syndrome often exhibit intense focus on specific subjects, engage in repetitive routines, and struggle with interpreting social cues, yet they typically possess average to above-average intelligence and experience no substantial delays in language acquisition.
The primary classifications under Asperger syndrome include Asperger syndrome itself, pervasive developmental disorder (PDD), autistic disorder, and disintegrative disorder. This condition is defined by persistent difficulties in social interactions and nonverbal communication, accompanied by repetitive or limited patterns of behavior and interests. Treatments usually consist of pharmacological interventions such as antipsychotics, selective serotonin reuptake inhibitors (SSRIs), stimulants, and medications for sleep disturbances. Diagnosis is made using a variety of tools, including the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV, differential diagnosis methods, the Childhood Asperger Syndrome Test, the Gilliam Asperger's Disorder Scale (GADS), and the Krug Asperger's Disorder Index (KADI), among others. Asperger syndrome affects people across all life stages-children, teenagers, and adults-and serves end users like hospitals, clinics, diagnostic centers, drugstores, pharmacies, and other healthcare facilities.
The asperger syndrome market research report is one of a series of new reports from The Business Research Company that provides asperger syndrome market statistics, including the asperger syndrome industry's global market size, regional shares, competitors with a asperger syndrome market share, detailed asperger syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the asperger syndrome industry. This asperger syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The asperger syndrome market size has grown strongly in recent years. It will grow from $1.62 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The factors contributing to historical growth include increased public understanding of autism spectrum conditions, higher funding allocations for neurological research, a rise in diagnosed cases, proactive government support, growth in mental health care facilities, and advocacy efforts from autism-related groups.
The asperger syndrome market size is expected to see strong growth in the next few years. It will grow to $2.12 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. Key drivers of this future growth include heightened awareness of autism spectrum disorders, broader implementation of early diagnostic technologies, greater access to behavioral and developmental therapy options, favorable healthcare policies and government programs, expansion of telemedicine and mental health platforms, and a growing incidence of psychological conditions. Emerging trends anticipated during the forecast period involve the use of artificial intelligence (AI) in early diagnosis, the rise of teletherapy services, innovations in personalized behavioral treatments, and the introduction of wearable monitoring tools.
The rising incidence of neurological disorders is anticipated to drive the growth of the asperger syndrome market in the coming years. Neurological disorders, which impact the brain, spinal cord, and nerves, manifest through cognitive, motor, and sensory impairments. Their increasing prevalence is largely attributed to the aging global population, as aging affects neuronal function, reduces brain plasticity, and heightens oxidative stress, all of which contribute to the development and progression of such conditions. These disorders influence brain development and function, particularly in areas associated with social interaction and communication, thereby contributing to the onset of asperger syndrome. They affect behavior by creating difficulties with social cues, fostering repetitive behaviors, and generating intense focus on specific interests-hallmarks of the condition. For example, in July 2024, the National Health Service (NHS), a UK-based government agency, reported that 487,432 patients had been diagnosed with dementia by June 30, 2024, marking an increase of 3,155 cases compared to May 31, 2024. Consequently, the growing prevalence of neurological disorders is a key factor propelling the asperger syndrome market.
Leading companies in the asperger syndrome market are increasingly investing in the development of advanced therapies, such as gene therapies, to address the root genetic causes, improve cognitive and social functioning, and support personalized treatment strategies. Gene therapies are treatments that involve modifying a person's genes to either prevent or cure diseases. For instance, in January 2024, Jaguar Gene Therapy, a US-based biotechnology firm, received clearance from the U.S. Food and Drug Administration (FDA) for its investigational new drug (IND) application for JAG201. This gene therapy is aimed at treating a genetic form of autism spectrum disorder (ASD) and Phelan-McDermid syndrome (PMS). The FDA's approval allows for clinical trials assessing JAG201's potential to correct SHANK3 deficiency, a major genetic factor in these disorders, and highlights Jaguar's dedication to creating transformative therapies for serious neurodevelopmental conditions with limited current treatment options.
In March 2024, Bristol-Myers Squibb, a US-based biopharmaceutical company, acquired Karuna Therapeutics Inc. for $14 billion. This acquisition included KarXT, a promising antipsychotic treatment for schizophrenia and psychosis related to Alzheimer's disease, thereby strengthening Bristol-Myers Squibb's neuroscience portfolio and signaling its return to neuropsychiatric drug development. Karuna Therapeutics Inc. is a US-based biopharmaceutical company specializing in neuropsychiatric treatments, which could have implications for conditions such as asperger syndrome.
Major players in the asperger syndrome market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim, Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Neurocrine Biosciences Inc., Acadia Pharmaceuticals Inc., PsychoGenics Inc., AdvaCare Pharma, Sage Therapeutics Inc., Curemark LLC, PaxMedica Inc., and Yamo Pharmaceuticals.
North America was the largest region in the asperger syndrome market in 2024. The regions covered in asperger syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the asperger syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The asperger syndrome market consists of revenues earned by entities by providing services such as behavioral therapy, occupational therapy, speech and language therapy, social skills training, psychological counseling, educational support programs, and diagnostic and assessment services. The market value includes the value of related goods sold by the service provider or included within the service offering. The asperger syndrome market also includes sales of assistive communication devices, sensory integration tools, educational software, specialized learning materials, therapeutic toys, and nutritional supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Asperger Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on asperger syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for asperger syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The asperger syndrome market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
2) By Treatment: Drug Therapies; Antipsychotic Drugs; Selective Serotonin Reuptake Inhibitors (SSRIs); Stimulants; Sleep Medication
3) By Diagnosis: Diagnostic And Statistical Manual Of Mental Disorders (DSM)-IV; Differential Diagnosis; Childhood Asperger Syndrome Test; Gilliam Asperger's Disorder Scale (Gads); Krug Asperger's Disorder Index (Kadi); Other Diagnosis
4) By Age Group: Children; Adolescents; Adults
5) By End-User: Hospitals; Clinics; Diagnostic Centres; Drug Stores; Pharmacies; Other End-Users
Segmentation:
1) By Asperger Syndrome: Mild Asperger Syndrome; Moderate Asperger Syndrome; Severe Asperger Syndrome
2) By Pervasive Developmental Disorder: Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS); Rett Syndrome; Childhood Disintegrative Disorder
3) By Autistic Disorder: High-functioning Autism; Low-functioning Autism; Classic Autism
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Asperger Syndrome Market Characteristics
3. Asperger Syndrome Market Trends And Strategies
4. Asperger Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Asperger Syndrome Growth Analysis And Strategic Analysis Framework
5.1. Global Asperger Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Asperger Syndrome Market Growth Rate Analysis
5.4. Global Asperger Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Asperger Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Asperger Syndrome Total Addressable Market (TAM)
6. Asperger Syndrome Market Segmentation
6.1. Global Asperger Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Asperger Syndrome
Pervasive Developmental Disorder
Autistic Disorder
Disintegrative Disorder
6.2. Global Asperger Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Therapies
Antipsychotic Drugs
Selective Serotonin Reuptake Inhibitors (SSRIs)
Stimulants
Sleep Medication
6.3. Global Asperger Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic And Statistical Manual Of Mental Disorders (DSM)-IV
Differential Diagnosis
Childhood Asperger Syndrome Test
Gilliam Asperger's Disorder Scale (Gads)
Krug Asperger's Disorder Index (Kadi)
Other Diagnosis
6.4. Global Asperger Syndrome Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Children
Adolescents
Adults
6.5. Global Asperger Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Diagnostic Centers
Drug Stores
Pharmacies
Other End-Users
6.6. Global Asperger Syndrome Market, Sub-Segmentation Of Asperger Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild Asperger Syndrome
Moderate Asperger Syndrome
Severe Asperger Syndrome
6.7. Global Asperger Syndrome Market, Sub-Segmentation Of Pervasive Developmental Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.8. Global Asperger Syndrome Market, Sub-Segmentation Of Autistic Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
High-functioning Autism
Low-functioning Autism
Classic Autism
6.9. Global Asperger Syndrome Market, Sub-Segmentation Of Disintegrative Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Late-Onset Autism
Regressive Autism
Behavioral Disintegration Subtypes
7. Asperger Syndrome Market Regional And Country Analysis
7.1. Global Asperger Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Asperger Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
